• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝动脉血流速率对钬微球分布的影响:灌注猪肝的MRI研究

The influence of hepatic arterial blood flow rate on holmium microsphere distribution: an MRI study in perfused porcine livers.

作者信息

Snoeijink Tess J, van den Brekel Anne, van der Hoek Jan L, Greve Jaap G M, Remco Liefers H, Boswinkel Milou, Ruiter Simon J S, Roosen Joey, Jebbink Erik Groot, Nijsen J Frank W

机构信息

Radboud University Medical Centre, Department of Medical Imaging, Nijmegen, The Netherlands.

University of Twente, TechMed Centre, Multi-Modality Medical Imaging Group, Enschede, The Netherlands.

出版信息

Eur Radiol Exp. 2025 Aug 6;9(1):69. doi: 10.1186/s41747-025-00609-7.

DOI:10.1186/s41747-025-00609-7
PMID:40770152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12328857/
Abstract

BACKGROUND

Transarterial radioembolisation (TARE) is a treatment for liver malignancies, involving the injection of radioactive microspheres in the hepatic artery (HA). Tumour-to-nontumour uptake varies among patients, possibly influenced by patient-specific blood flow profiles. To examine the impact of HA blood flow rate and high microsphere dosages on microsphere distribution in normal liver parenchyma, ex vivo magnetic resonance imaging (MRI)-guided machine perfusion experiments were conducted in porcine livers.

MATERIALS AND METHODS

Porcine livers were subjected to oxygenated normothermic machine perfusion at three HA flow rates (0.02, 0.15, and 0.22 mL/min/g liver tissue; n = 3 per condition). Five fractions of 250 mg nonradioactive Ho-loaded microspheres were administered to n = 9 livers, and four additional fractions of 1,000 mg to n = 6 livers. Dynamic contrast-enhanced and Ho-sensitive T2*-weighed MR scans were acquired to extract perfusion rates, fictive dose maps, and homogeneity indices (HI).

RESULTS

Microsphere distribution correlated moderately with perfusion rate at low HA flow rate (r = 0.611), and very strongly at higher HA flow rates (r = 0.977 and 0.951 for 0.15 and 0.22 mL/min/g, respectively). Homogeneity increased with increasing flow rates, with HIs ranging from 3.68-4.72 at low, to 2.01-2.66 at medium, and 1.60-2.36 at high HA flow rate. HI decreased with higher microsphere concentrations, though distribution patterns remained unchanged.

CONCLUSION

In our ex vivo model, higher HA flow rates resulted in more homogeneous microsphere distributions. The impact on tumourous tissue needs further investigation to determine whether pre-TARE HA blood flow measurements could improve microsphere distribution predictions.

RELEVANCE STATEMENT

Mapping of the hepatic arterial blood flow rate before transarterial radioembolisation and adjusting the treatment accordingly may help to improve outcomes for patients with liver cancer.

KEY POINTS

Parameters influencing microsphere distribution were studied in MRI-perfused healthy porcine livers. Higher hepatic arterial blood flow rates led to more homogeneous microsphere distributions. Administering large numbers of microspheres did not alter microsphere distribution patterns. Impact on tumour tissue should be further investigated.

摘要

背景

经动脉放射性栓塞术(TARE)是一种治疗肝脏恶性肿瘤的方法,包括在肝动脉(HA)中注射放射性微球。患者之间肿瘤与非肿瘤的摄取情况各不相同,可能受到患者特异性血流情况的影响。为了研究肝动脉血流速率和高微球剂量对正常肝实质中微球分布的影响,在猪肝脏中进行了体外磁共振成像(MRI)引导的机器灌注实验。

材料与方法

对猪肝脏以三种肝动脉血流速率(0.02、0.15和0.22 mL/min/g肝组织;每种情况n = 3)进行含氧常温机器灌注。向n = 9个肝脏注射五剂250 mg载钬非放射性微球,向n = 6个肝脏额外注射四剂1000 mg。采集动态对比增强和钬敏感T2*加权磁共振扫描,以提取灌注速率、虚拟剂量图和均匀性指数(HI)。

结果

在低肝动脉血流速率下,微球分布与灌注速率中度相关(r = 0.611),在较高肝动脉血流速率下相关性非常强(0.15和0.22 mL/min/g时r分别为0.977和0.951)。均匀性随血流速率增加而增加,低血流速率下HI范围为3.68 - 4.72,中等血流速率下为2.01 - 2.66,高肝动脉血流速率下为1.60 - 2.36。HI随微球浓度升高而降低,不过分布模式保持不变。

结论

在我们的体外模型中,较高的肝动脉血流速率导致微球分布更均匀。对肿瘤组织的影响需要进一步研究,以确定TARE前肝动脉血流测量是否能改善微球分布预测。

相关性声明

经动脉放射性栓塞术前绘制肝动脉血流速率图并相应调整治疗,可能有助于改善肝癌患者的治疗效果。

关键点

在MRI灌注的健康猪肝脏中研究了影响微球分布的参数。较高的肝动脉血流速率导致微球分布更均匀。大量注射微球并未改变微球分布模式。对肿瘤组织的影响应进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e282/12328857/d93504c73df3/41747_2025_609_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e282/12328857/d93504c73df3/41747_2025_609_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e282/12328857/d93504c73df3/41747_2025_609_Fig8_HTML.jpg

相似文献

1
The influence of hepatic arterial blood flow rate on holmium microsphere distribution: an MRI study in perfused porcine livers.肝动脉血流速率对钬微球分布的影响:灌注猪肝的MRI研究
Eur Radiol Exp. 2025 Aug 6;9(1):69. doi: 10.1186/s41747-025-00609-7.
2
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.钇-90微球放射性栓塞治疗不可切除的肝细胞癌
Cochrane Database Syst Rev. 2016 Feb 16;2:CD011313. doi: 10.1002/14651858.CD011313.pub2.
3
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
4
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.经动脉(化疗)栓塞与全身化疗治疗结直肠癌肝转移。
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.
5
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
6
Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.经动脉(化疗)栓塞术与不进行干预或安慰剂干预治疗肝转移瘤的比较
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009498. doi: 10.1002/14651858.CD009498.pub3.
7
Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.经动脉(化疗)栓塞术与不干预或安慰剂干预治疗肝转移瘤的比较
Cochrane Database Syst Rev. 2012 Sep 12(9):CD009498. doi: 10.1002/14651858.CD009498.pub2.
8
Gene therapy for people with hepatocellular carcinoma.肝细胞癌的基因治疗。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013731. doi: 10.1002/14651858.CD013731.pub2.
9
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
10
The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.动脉内注射血管紧张素II对放射性栓塞中肝肿瘤与非肿瘤血流比的影响:一项系统评价
PLoS One. 2014 Jan 17;9(1):e86394. doi: 10.1371/journal.pone.0086394. eCollection 2014.

本文引用的文献

1
Development and evaluation of a variable, miniaturized oxygenator for various test methods.一种适用于多种测试方法的可变小型化氧合器的研发与评估。
Artif Organs. 2023 Apr;47(4):695-704. doi: 10.1111/aor.14465. Epub 2022 Dec 2.
2
Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery.钬-166 微球经动脉放射栓塞治疗肝脏肿瘤术中 MRI 剂量学研究(EMERITUS-1):向自适应、图像控制治疗输送迈进的 I 期试验。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4705-4715. doi: 10.1007/s00259-022-05902-w. Epub 2022 Jul 13.
3
The importance of CT perfusion for diagnosis and treatment of ischemic stroke in anterior circulation.
CT 灌注在诊断和治疗前循环缺血性脑卒中中的重要性。
J Integr Neurosci. 2022 May 12;21(3):92. doi: 10.31083/j.jin2103092.
4
The Impact of Injection Distance to Bifurcations on Yttrium-90 Distribution in Liver Cancer Radioembolization.注射距离对肝癌放射性栓塞中钇-90 分布的影响。
J Vasc Interv Radiol. 2022 Jun;33(6):668-677.e1. doi: 10.1016/j.jvir.2022.03.006. Epub 2022 Mar 15.
5
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.EANM 实践指南:经动脉放射性化合物治疗肝癌和肝转移瘤。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1682-1699. doi: 10.1007/s00259-021-05600-z. Epub 2022 Feb 11.
6
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐:2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
7
Transarterial drug delivery for liver cancer: numerical simulations and experimental validation of particle distribution in patient-specific livers.经动脉药物输送治疗肝癌:特定患者肝脏中粒子分布的数值模拟与实验验证。
Expert Opin Drug Deliv. 2021 Mar;18(3):409-422. doi: 10.1080/17425247.2021.1853702. Epub 2020 Dec 14.
8
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.个体化与标准剂量测定法在局部进展期肝细胞癌患者选择性内放射治疗中的应用(DOSISPHERE-01):一项随机、多中心、开放标签的 2 期试验。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7.
9
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Y in the SARAH Study.SARAH 研究中钇[90Y]放射性微球内放射栓塞治疗肝细胞癌的肿瘤吸收剂量与生存和反应的关系。
Radiology. 2020 Sep;296(3):673-684. doi: 10.1148/radiol.2020191606. Epub 2020 Jun 30.
10
Holmium-166 Microsphere Radioembolization of Hepatic Malignancies.钬-166 微球放射性栓塞治疗肝脏恶性肿瘤。
Semin Nucl Med. 2019 May;49(3):237-243. doi: 10.1053/j.semnuclmed.2019.01.008. Epub 2019 Feb 1.